Legacy Research Phase Concluded
Development and fulfillment for Tirzepatide 5mg has been prioritized for next-generation research compounds. We recommend exploring our state-of-the-art triple-agonist formulation.
Tirzepatide 5mg
starting concentration for initial titration and concentration-finding protocols. Dual GLP-1/GIP receptor agonist used in metabolic pathway research.
Secure checkout and fulfillment via Particle Peptides (Official 2026 Partner).
SKU: BBL-15-5mg-seo
Fulfillment: Direct from Particle Peptides EU
Product Overview
starting concentration for initial titration and concentration-finding protocols. Dual GLP-1/GIP receptor agonist used in metabolic pathway research.
This research-grade peptide is distributed in partnership with Particle Peptides to ensure maximum freshness and rapid delivery. Each batch undergoes rigorous third-party testing including HPLC and mass spectrometry.
Related Research Peptides
Tirzepatide
Tirzepatide research compound. Dual GLP-1/GIP receptor agonist used in metabolic pathway research and incretin hormone studies. For qualified researchers conducting scientific experiments only.
AOD9604
AOD9604 research peptide. Modified growth hormone fragment for lipolysis and lipid metabolism studies. Used in fat metabolism research without affecting glucose homeostasis. For laboratory research purposes only.
Tirzepatide 10mg
Standard maintenance concentration for established metabolic research protocols. Dual GLP-1/GIP receptor agonist.
Tirzepatide 15mg
Maximum strength for advanced research protocols and optimal pathway investigation.
€105
Partner Stock